These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37100824)

  • 41. The success rate and complications of midline catheters in pediatric outpatient parenteral antibiotic therapy (OPAT).
    Fläring U; Lundevall H; Norberg Å; Andersson A
    Eur J Pediatr; 2024 Apr; 183(4):1703-1709. PubMed ID: 38227054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
    Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
    Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the relationship between patient characteristics and complication in veterans discharged on parenteral antibiotic therapy.
    Guenther ED; Sherman KA; Dysart CE; Haque J; Mahatme S; Gundacker ND
    Res Social Adm Pharm; 2022 Oct; 18(10):3864-3866. PubMed ID: 35437231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
    Gilchrist M; Seaton RA
    J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.
    Kieran J; O'Reilly A; Parker J; Clarke S; Bergin C
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1369-74. PubMed ID: 19697069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of Outpatient Parenteral Antimicrobial Therapy in Patients With Injection Drug Use.
    Vazirian M; Jerry JM; Shrestha NK; Gordon SM
    Psychosomatics; 2018; 59(5):490-495. PubMed ID: 29685397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines.
    Ng N; Bailey P; Pryor R; Fung L; Veals C; Sabouri K; Reznicek J
    Antimicrob Steward Healthc Epidemiol; 2021; 1(1):e42. PubMed ID: 36168502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.
    Chary A; Tice AD; Martinelli LP; Liedtke LA; Plantenga MS; Strausbaugh LJ;
    Clin Infect Dis; 2006 Nov; 43(10):1290-5. PubMed ID: 17051494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.
    Li W; Branley J; Sud A
    Infection; 2018 Jun; 46(3):349-355. PubMed ID: 29464675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twice daily cefazolin is effective for treatment of serious methicillin-sensitive
    Birrell MT; Fuller A
    Ther Adv Infect Dis; 2019; 6():2049936119882847. PubMed ID: 31839941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal use via outpatient parenteral antimicrobial therapy.
    Chew SM; Heath CH; Petursson C; Boan PA; Robinson JO; Italiano CM; Dyer JR; Manning L; Ingram PR
    Mycoses; 2022 Oct; 65(10):946-952. PubMed ID: 35923125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
    Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
    Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
    Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
    Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.
    Duncan CJ; Barr DA; Seaton RA
    Int J Clin Pharm; 2012 Jun; 34(3):410-7. PubMed ID: 22527482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
    Sumpter C; Russell CD; Mackintosh C
    Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.